ArticleOncoimmunology
HVEM has a broader expression than PD-L1 and constitutes a negative prognostic marker and potential treatment target for melanoma.
Nausicaa Malissen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
39 papers cite it
cites it